Azasan

Active Ingredient(s): Azathioprine
FDA Approved: * June 7, 1999
Pharm Company: * AAIPHARMA LLC
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Azasan Overview

Azathioprine (AZA), sold under the brand name Imuran among others, is an immunosuppressive medication.[2] It is used in rheumatoid arthritis, granulomatosis with polyangiitis, Crohn's disease, ulcerative colitis, and in kidney transplants to prevent rejection.[2][3][4] It is taken by mouth or injected into a vein.[2] Common side effect include bone marrow suppression and vomiting.[2] Bone marrow su...

Read more Azasan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Azathioprine

Recent Azasan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Azathioprine
  • Injection: 100mg, 100mg/vial
  • Tablet: 100mg, 25mg, 50mg, 75mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Azasan: (2 results)

Sorted by National Drug Code
  • 65649-231 Azasan 75 mg Oral Tablet by Salix Pharmaceuticals, Inc.
  • 65649-241 Azasan 100 mg Oral Tablet by Salix Pharmaceuticals, Inc.

Other drugs which contain Azathioprine or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA